The Effect of Administrative Cessation of the Use of Ipratropium Bromide in the Treatment of Acute Asthma Attacks in the Emergency Department

Rachel DanknerThe Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Ramat Gan, Israel;School for Public Health, Sackler Faculty for Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]

, M.d.,

Cindy CohenThe Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Ramat Gan, Israel

, M.A.,

Liraz OlmerThe Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Ramat Gan, Israel

, M.Sc.,

Ilya NovikovThe Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Ramat Gan, Israel

, Ph.D.,

Ariel BentancurSchool for Public Health, Sackler Faculty for Medicine, Tel Aviv University, Tel Aviv, Israel;Emergency Department, Sheba Medical Center, Ramat Gan, Israel

, M.D.,

Arnona ZivThe Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Ramat Gan, Israel

, M.B.A. &

Amir ShaharSchool for Public Health, Sackler Faculty for Medicine, Tel Aviv University, Tel Aviv, Israel;Emergency Department, Sheba Medical Center, Ramat Gan, Israel

, M.d. show all

The Effect of Administrative Cessation of the Use of Ipratropium Bromide in the Treatment of Acute Asthma Attacks in the Emergency Department

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Effect of Administrative Cessation of the Use of Ipratropium Bromide in the Treatment of Acute Asthma Attacks in the Emergency Department

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date